1. Home
  2. POLA vs VIRX Comparison

POLA vs VIRX Comparison

Compare POLA & VIRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POLA
  • VIRX
  • Stock Information
  • Founded
  • POLA 1979
  • VIRX 2007
  • Country
  • POLA United States
  • VIRX United States
  • Employees
  • POLA N/A
  • VIRX N/A
  • Industry
  • POLA Industrial Machinery/Components
  • VIRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • POLA Miscellaneous
  • VIRX Health Care
  • Exchange
  • POLA Nasdaq
  • VIRX Nasdaq
  • Market Cap
  • POLA 8.3M
  • VIRX 6.8M
  • IPO Year
  • POLA 2016
  • VIRX N/A
  • Fundamental
  • Price
  • POLA $2.85
  • VIRX $0.08
  • Analyst Decision
  • POLA
  • VIRX Buy
  • Analyst Count
  • POLA 0
  • VIRX 4
  • Target Price
  • POLA N/A
  • VIRX $5.00
  • AVG Volume (30 Days)
  • POLA 19.2K
  • VIRX 2.1M
  • Earning Date
  • POLA 11-14-2024
  • VIRX 03-06-2025
  • Dividend Yield
  • POLA N/A
  • VIRX N/A
  • EPS Growth
  • POLA N/A
  • VIRX N/A
  • EPS
  • POLA N/A
  • VIRX N/A
  • Revenue
  • POLA $14,953,000.00
  • VIRX N/A
  • Revenue This Year
  • POLA $6.72
  • VIRX N/A
  • Revenue Next Year
  • POLA N/A
  • VIRX N/A
  • P/E Ratio
  • POLA N/A
  • VIRX N/A
  • Revenue Growth
  • POLA N/A
  • VIRX N/A
  • 52 Week Low
  • POLA $2.31
  • VIRX $0.07
  • 52 Week High
  • POLA $4.90
  • VIRX $1.31
  • Technical
  • Relative Strength Index (RSI)
  • POLA 45.18
  • VIRX 20.79
  • Support Level
  • POLA $3.07
  • VIRX $0.14
  • Resistance Level
  • POLA $2.97
  • VIRX $0.19
  • Average True Range (ATR)
  • POLA 0.11
  • VIRX 0.02
  • MACD
  • POLA -0.03
  • VIRX -0.01
  • Stochastic Oscillator
  • POLA 22.22
  • VIRX 0.00

About POLA Polar Power Inc.

Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications primarily in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, Back-up DC generators, hybrid power systems, Li-Ion battery systems, and Marine DC generators. The Companie's geographical presence is in the United States, Canada, Mexico, South Pacific Islands, Japan, Europe and Middle East and Other Asia Pacific countries.

About VIRX Viracta Therapeutics Inc.

Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein-Barr virus-positive lymphoma. The product candidate of the company is a combination product candidate consisting of nanatinostat, a potent and selective small molecule inhibitor of class I histone deacetylases (HDAC), and valganciclovir, an FDA-approved anti-viral drug used to treat and prevent disease caused by a virus called cytomegalovirus (CMV) in people with organ transplants.

Share on Social Networks: